355
Participants
Start Date
May 24, 2016
Primary Completion Date
May 31, 2019
Study Completion Date
September 30, 2023
Human Acellular Vessel (HAV)
HAV-tissue-engineered vascular conduit (6mm diameter)
ePTFE graft
One of two commercially available comparators (Bard Impra® and Gore PROPATEN®)
University of Maryland Medical Center, Baltimore
Duke University Hospital, Durham
Medical University of South Carolina (MUSC), Orangeburg
University of South Florida, Tampa
Hillel Jaffe Medical Center, Hadera
Greenwood Leflore Hospital, Greenwood
Michigan Cardiovascular Institute, Flint
The Chaim Sheba Medical Center, Ramat Gan
University of Wisconsin, Madison
Universitätsklinikum Frankfurt Klinik für Gefäß- und Endovascular-Chirurgie, Frankfurt am Main
Southwest Vascular Access Center, Alsip
Washington University School of Medicine, St Louis
Yitzhak Shamir Medical Center - Assaf Harofeh, Tzrifin
Baylor Scott and White Research Institute, Dallas
Arizona Kidney Disease and Hypertension Center (AKDHC), Phoenix
Carondelet St. Mary's Hospital, Tucson
VA Long Beach Healthcare System, Long Beach
Universitätsklinikmn Erlangen, Gefäßchirurgie - Chirurgisches Zentrum, Erlangen
Balboa Nephrology, San Diego
University of California Irvine (UCI) Medical Center, Irvine
Ladenheim Dialysis Access Center, Fresno
General Surgery and Vascular Access, Fresno
VA Sacramento Medical Center, Mather
Kaiser Permanente, Portland
Rambam Health Care Campus, Haifa
Sharee Zedek Medical Center, Jerusalem
Brigham and Women's Hospital, Boston
Rutgers-New Jersey Medical School, Newark
The Cardiovascular Care Group, Westfield
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego, Poznan
Samodzielny Publiczyn Centralny Szpital Klinziczny w Warszawie - Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Warsaw
Wojewódzki Szpital Specjalistyczny we Wrocławiu, Wroclaw
Grupo de Estudos Vasculares, Porto
Leicester General Hospital, Leicester
Guy´s Hospital, Kings´College London, London
Queen Elizabeth Hospital Birmingham, Birmingham
Queen Elizabeth University Hospital Glasgow, Glasgow
Leeds General Infirmary, Leeds
Lead Sponsor
Collaborators (1)
CTI Clinical Trial and Consulting Services
OTHER
California Institute for Regenerative Medicine (CIRM)
OTHER
Humacyte, Inc.
INDUSTRY